Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
A new recall for Abiomed | Previewing ESC Congress 2023 | Implantation depth & LAAO outcomes
Monday, August 21, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Abiomed recalls heart pump catheter labeling after 12 injuries

This is a Class I recall, which means using the devices “may cause serious injuries or death.” The catheter's instructions have been updated to reduce the risk of complications going forward. 

READ MORE >
FDA Recall
Share on Twitter Share on Facebook Share on Linkedin

Abiomed recalls heart pump catheter labeling after 12 injuries

Share on Twitter Share on Facebook Share on Linkedin
FDA Recall
This is a Class I recall, which means using the devices “may cause serious injuries or death.” The catheter's instructions have been updated to reduce the risk of complications going forward. 
READ MORE >

ESC Congress 2023 to feature 30 late-breaking clinical trials

The European Society of Cardiology's annual meeting is scheduled for Aug. 25-28, 2023, in Amsterdam.

READ MORE >
A complete list of the European Society of Cardiology (ESC) 2023 Congress late-breaking Hot Line sessions. #ESCCongress
Share on Twitter Share on Facebook Share on Linkedin

ESC Congress 2023 to feature 30 late-breaking clinical trials

Share on Twitter Share on Facebook Share on Linkedin
A complete list of the European Society of Cardiology (ESC) 2023 Congress late-breaking Hot Line sessions. #ESCCongress
The European Society of Cardiology's annual meeting is scheduled for Aug. 25-28, 2023, in Amsterdam.
READ MORE >

Mitigating risk: How the depth of device implantation impacts LAAO outcomes

Researchers examined data from more than 1,300 procedures, presenting their findings in JACC: Cardiovascular Interventions.

READ MORE >
The depth of left atrial appendage occlusion (LAAO) devices inside the LAA impacts outcomes. #LAAO
Share on Twitter Share on Facebook Share on Linkedin

Mitigating risk: How the depth of device implantation impacts LAAO outcomes

Share on Twitter Share on Facebook Share on Linkedin
The depth of left atrial appendage occlusion (LAAO) devices inside the LAA impacts outcomes. #LAAO
Researchers examined data from more than 1,300 procedures, presenting their findings in JACC: Cardiovascular Interventions.
READ MORE >

Featured Articles

FDA announces yet another recall, the fifth of 2023, for troubled heart devices

The latest Class I recall is due to mechanical issues that can cause the devices to stop charging their batteries. 

READ MORE >
the words "FDA recall" on a board
Share on Twitter Share on Facebook Share on Linkedin

FDA announces yet another recall, the fifth of 2023, for troubled heart devices

Share on Twitter Share on Facebook Share on Linkedin
the words "FDA recall" on a board
The latest Class I recall is due to mechanical issues that can cause the devices to stop charging their batteries. 
READ MORE >

Interventional echocardiographers play a key role in the treatment of structural heart disease

Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid.

READ MORE >
Video of Rebecca Hahn, MD, explains the roles and economics of interventional echocardiographers. #ASE #ASE23 #Structuralheart #echofirst
Share on Twitter Share on Facebook Share on Linkedin

Interventional echocardiographers play a key role in the treatment of structural heart disease

Share on Twitter Share on Facebook Share on Linkedin
Video of Rebecca Hahn, MD, explains the roles and economics of interventional echocardiographers. #ASE #ASE23 #Structuralheart #echofirst
Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid.
READ MORE >

AI spots critical heart defects missed by the human eye

“If we can deploy our model on a population-level ECG screening, we would be able to pick up many more of these patients before they have irreversible damage,” a cardiologist behind the new study explained. 

READ MORE >
artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google
Share on Twitter Share on Facebook Share on Linkedin

AI spots critical heart defects missed by the human eye

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI deep learning ChatGPT OpenAI Microsoft Google
“If we can deploy our model on a population-level ECG screening, we would be able to pick up many more of these patients before they have irreversible damage,” a cardiologist behind the new study explained. 
READ MORE >

In Case You Missed It

How medical imaging helps cardiologists treat hypertrophic cardiomyopathy

Hypertrophic cardiomyopathy expert Sherif F. Nagueh, MD, examined imaging's role in treating this serious condition. 

READ MORE >
HCM expert Sherif F. Nagueh, MD, FACC, FASE, professor of cardiology, Methodist DeBakey Heart and Vascular Center, explains the key points of HCM imaging. #ASE #HCM
Share on Twitter Share on Facebook Share on Linkedin

How medical imaging helps cardiologists treat hypertrophic cardiomyopathy

Share on Twitter Share on Facebook Share on Linkedin
HCM expert Sherif F. Nagueh, MD, FACC, FASE, professor of cardiology, Methodist DeBakey Heart and Vascular Center, explains the key points of HCM imaging. #ASE #HCM
Hypertrophic cardiomyopathy expert Sherif F. Nagueh, MD, examined imaging's role in treating this serious condition. 
READ MORE >

A surgeon's perspective on treating hypertrophic cardiomyopathy

Nicholas Smedira, MD, a cardiovascular surgeon with Cleveland Clinic, discusses septal myectomy and the need to improve overall HCM care with new standards and evidence-based guidelines.

READ MORE >
Photo of a surgical cardiac septal myectomy to treat hypertrophic cardiomyopathy (HCM). Nicholas Smedira MD discusses septal myectomy in HCM patients and the need for more detailed protocols for HCM care. #HCM #ASE #ASE2023 #myectomy
Share on Twitter Share on Facebook Share on Linkedin

A surgeon's perspective on treating hypertrophic cardiomyopathy

Share on Twitter Share on Facebook Share on Linkedin
Photo of a surgical cardiac septal myectomy to treat hypertrophic cardiomyopathy (HCM). Nicholas Smedira MD discusses septal myectomy in HCM patients and the need for more detailed protocols for HCM care. #HCM #ASE #ASE2023 #myectomy
Nicholas Smedira, MD, a cardiovascular surgeon with Cleveland Clinic, discusses septal myectomy and the need to improve overall HCM care with new standards and evidence-based guidelines.
READ MORE >

In Other News

‘Gray market’ vendors hike up prices during drug shortages, leaving hospitals in a bind

Hospital executives find themselves in a challenging position—pay big bucks for hard-to-find medications or risk letting their patients down. 

READ MORE >
The U.S. Food and Drug Administration (FDA) has issued a new draft guidance designed to help applicants add clinically relevant information about QTc interval prolongation to the labeling of non-antiarrhythmic drugs
Share on Twitter Share on Facebook Share on Linkedin

‘Gray market’ vendors hike up prices during drug shortages, leaving hospitals in a bind

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) has issued a new draft guidance designed to help applicants add clinically relevant information about QTc interval prolongation to the labeling of non-antiarrhythmic drugs
Hospital executives find themselves in a challenging position—pay big bucks for hard-to-find medications or risk letting their patients down. 
READ MORE >

GPT-4, a new upgrade from the team behind ChatGPT, can help doctors with difficult diagnoses

The new and improved AI-based language model outperformed human clinicians in a new study published in JAMA Network Open.

READ MORE >
artificial intelligence consultation
Share on Twitter Share on Facebook Share on Linkedin

GPT-4, a new upgrade from the team behind ChatGPT, can help doctors with difficult diagnoses

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence consultation
The new and improved AI-based language model outperformed human clinicians in a new study published in JAMA Network Open.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup